ENZ logo

Enzo Biochem (ENZ)

Profile

Full Name

Enzo Biochem, Inc.

Ticker Symbol

ENZ

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

June 12, 1980

Indexes

Not included

Website

http://www.enzo.com

Employees

125

Key Details

Price

$0.31(-17.42%)

Market cap

Last Dividend

$0.10

TTM Dividend yield

31.87%

Annual revenue

$31.91M(+2.72% YoY)

Annual EPS

-$0.51(-224.39% YoY)

PE ratio

-

Next earnings date

Jun 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.31
ENZ price is $0.31

30-Day Relative Volume

9.08
ENZ 30-day relative volume is 9.08

Price Performance

Price Most recent change

-17.42%
ENZ price was down -17.42% on Apr 17, 2025

Price YTD change

-55.8%
ENZ price is down -55.8% since January 1st

Price 1-year change

-72.71%
ENZ price is down -72.71% year-on-year

Price 3-year change

-89.1%
ENZ price is down -89.1% over the past 3 years

Price Range

Price All-time high

$114.36
ENZ price is currently -99.73% below its historical high of $114.36

Price 3-year low

$0.25
ENZ price is currently +25.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$16.44M
ENZ market capitalization is $16.44 million

Market cap 3-year change

-88.28%
ENZ market capitalization is down -88.28% over the past 3 years

Market cap All-time high

$3.06B
ENZ market capitalization is currently -99.46% below its historical high of $3.06 billion

Market cap sector rank

25.66%
ENZ market capitalization is higher than 25.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.3%
ENZ shares outstanding is up +2.3% year-on-year

Shares Outstanding 3-Year Change

+7.58%
ENZ shares outstanding is up +7.58% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.66
ENZ beta is 0.66

200-day SMA

$0.87
ENZ price is currently -63.98% below its 200-day simple moving average

50-day SMA

$0.44
ENZ price is currently -29.42% below its 50-day simple moving average

RSI

40.82
ENZ 14-day relative strength index is 40.82

Volume

9.08
ENZ 30-day relative volume is 9.08

ATR

$0.06
ENZ average true range is $0.06

10-day Historical Volatility

220.52%
ENZ 10-day historical volatility is 220.52%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.10
ENZ last dividend was $0.10 per share, with an ex-dividend date of November 15, 2024

Next Dividend

-
ENZ next dividend has not yet been announced

Dividend per share

Dividend per share

-
ENZ annual dividend per share value is unknown

Dividend per share Sector Rank

-
ENZ annual dividend per share is unknown

Dividend per share 1-Year Change

-
ENZ annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
ENZ annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
ENZ annual dividend yield value is unknown

Dividend yield Sector Rank

-
ENZ annual dividend yield is unknown

Other

Payout ratio

-
ENZ annual payout ratio value is unknown

Dividends paid

-
ENZ annual dividends paid value is unknown

Free cash flow

-$26.80M
ENZ annual free cash flow is -$26.80 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$31.91M
ENZ annual revenue is $31.91 million

Revenue Analysts estimate

-
ENZ annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+2.72%
ENZ annual revenue is up +2.72% year-on-year

Revenue Sector rank

40.02%
ENZ annual revenue is higher than 40.02% of companies in Healthcare sector

EPS

EPS

-$0.51
ENZ annual earnings per share is -$0.51

EPS Analysts estimate

-
ENZ annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-224.39%
ENZ annual earnings per share is down -224.39% year-on-year

EPS Sector rank

68.27%
ENZ annual earnings per share is higher than 68.27% of companies in Healthcare sector

Profit

Gross profit

$14.63M
ENZ annual gross profit is $14.63 million

Gross margin

45.86%
ENZ annual gross profit margin is 45.86%

Operating profit

-$12.37M
ENZ annual operating income is -$12.37 million

Operating margin

-38.75%
ENZ annual operating profit margin is -38.75%

Net income

-$26.08M
ENZ annual net profit is -$26.08 million

Net margin

-81.73%
ENZ annual net profit margin is -81.73%

Expenses

Total expenses

$44.27M
ENZ annual total expenses is $44.27 million

Operating expenses

$27.00M
ENZ annual total operating expenses is $27.00 million

Cost of goods sold

$17.27M
ENZ annual cost of goods sold is $17.27 million

Selling, general & administrative expenses

$24.36M
ENZ annual SGA is $24.36 million

Depreciation and amortization

$1.27M
ENZ annual depreciation & amortization is $1.27 million

Interest expense

$197.00K
ENZ annual interest expense is $197.00 thousand

Income tax

$0.00
ENZ annual income tax is $0.00

EBIT & EBITDA

EBIT

-$9.62M
ENZ annual earnings before interest & taxes is -$9.62 million

EBITDA

-$8.35M
ENZ annual EBITDA is -$8.35 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$85.76M
ENZ annual total assets is $85.76 million

Non current assets

$15.73M
ENZ annual long term assets is $15.73 million

Current assets

$70.03M
ENZ annual total current assets is $70.03 million

Cash and cash equivalents

$52.37M
ENZ annual cash & cash equivalents is $52.37 million

Accounts receivable

$3.99M
ENZ annual accounts receivable is $3.99 million

Inventory

$6.83M
ENZ annual inventory is $6.83 million

Liabilities

Total liabilities

$29.65M
ENZ annual total liabilities is $29.65 million

Long term liabilities

$4.86M
ENZ annual total long term liabilities is $4.86 million

Current liabilities

$24.79M
ENZ annual total current liabilities is $24.79 million

Accounts payable

$1.38M
ENZ annual accounts payable is $1.38 million

Debt

Total debt

$3.51M
ENZ annual total debt is $3.51 million

Total debt 1-year change

-49.86%
ENZ annual total debt is down -49.86% year-on-year

Long term debt

$2.59M
ENZ annual long term debt is $2.59 million

Short term debt

$917.00K
ENZ annual short term debt is $917.00 thousand

Equity & Capital

Shareholders equity

$56.11M
ENZ annual stockholders equity is $56.11 million

Book value

$56.11M
ENZ annual book value is $56.11 million

Retained earnings

-$294.43M
ENZ annual retained earnings is -$294.43 million

Working capital

$45.24M
ENZ annual working capital is $45.24 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$26.26M
ENZ annual cash flow from operations is -$26.26 million

Cash from operations 1-year change

+28.98%
ENZ annual cash flow from operations is up +28.98% year-on-year

Cash from investing

-$545.00K
ENZ annual cash flow from investing activities is -$545.00 thousand

Cash from investing 1-year change

-100.55%
ENZ annual cash flow from investing activities is down -100.55% year-on-year

Cash from financing

-$4.19M
ENZ annual cash flow from financing activities is -$4.19 million

Cash from financing 1-year change

-272.71%
ENZ annual cash flow from financing activities is down -272.71% year-on-year

CAPEX

CAPEX

$545.00K
ENZ annual capital expenditures is $545.00 thousand

CAPEX 1-year change

-80.25%
ENZ annual capital expenditures is down -80.25% year-on-year

Free Cash Flow

Free cash flow

-$26.80M
ENZ annual free cash flow is -$26.80 million

Free cash flow 1-year change

+32.54%
ENZ annual free cash flow is up +32.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.86%
ENZ annual gross profit margin is 45.86%

Operating margin

-38.75%
ENZ annual operating profit margin is -38.75%

Net margin

-81.73%
ENZ annual net profit margin is -81.73%

ROA & ROE

ROA

-25.12%
ENZ annual return on assets is -25.12%

ROE

-38.76%
ENZ annual return on equity is -38.76%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ENZ price to earnings ratio value is unknown

PE ratio Sector rank

-
ENZ price to earnings ratio is unknown

PB Ratio

PB ratio

0.35
ENZ price to book ratio is 0.35

PB ratio Sector rank

25.04%
ENZ price to book ratio is higher than 25.04% of companies in Healthcare sector

PS Ratio

PS ratio

0.57
ENZ price to sales ratio is 0.57

PS ratio Sector rank

19.49%
ENZ price to sales ratio is higher than 19.49% of companies in Healthcare sector

Enterprise value

Enterprise value

-$20.72M
ENZ enterprise value is -$20.72 million

Enterprise value Sector rank

3.14%
ENZ enterprise value is higher than 3.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.56
ENZ EV/EBITDA is 3.56

EV/EBITDA Sector rank

77.3%
ENZ EV/EBITDA is higher than 77.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.82
ENZ annual current ratio is 2.82

Quick ratio

2.55
ENZ annual quick ratio is 2.55

Leverage

Debt to equity

0.00
ENZ annual debt to equity ratio is 0.00

Interest coverage ratio

-48.83
ENZ annual interest coverage ratio is -48.83

Risk & Stability

Piotroski F-Score

4
ENZ piotroski f-score is 4

Altman Z-Score

-3.84
ENZ altman z-score is -3.84

Analyst ratings

Recent major analysts updates

Feb 4, 14 Craig-Hallum
Buy
Jul 2, 13 Sidoti & Co.
Neutral

Institutional Ownership

Similar stocks

UBX logo
Unity Biotechnology (UBX)
IXHL logo
Incannex Healthcare Limited (IXHL)
EQ logo
Equillium (EQ)
LPCN logo
Lipocine (LPCN)
ALLR logo
Allarity Therapeutics (ALLR)
IRIX logo
IRIDEX (IRIX)
BCTX logo
BriaCell Therapeutics (BCTX)
EDSA logo
Edesa Biotech (EDSA)
HBIO logo
Harvard Bioscience (HBIO)
  • What is the ticker symbol for Enzo Biochem?
  • Does Enzo Biochem pay dividends?
  • What sector is Enzo Biochem in?
  • What industry is Enzo Biochem in?
  • What country is Enzo Biochem based in?
  • When did Enzo Biochem go public?
  • Is Enzo Biochem in the S&P 500?
  • Is Enzo Biochem in the NASDAQ 100?
  • Is Enzo Biochem in the Dow Jones?
  • When was Enzo Biochem's last earnings report?
  • When does Enzo Biochem report earnings?

What is the ticker symbol for Enzo Biochem?

The ticker symbol for Enzo Biochem is NYSE:ENZ

Does Enzo Biochem pay dividends?

Yes, Enzo Biochem pays dividends. The last payment was $0.10, with an ex-dividend date on November 15, 2024

What sector is Enzo Biochem in?

Enzo Biochem is in the Healthcare sector

What industry is Enzo Biochem in?

Enzo Biochem is in the Diagnostics & Research industry

What country is Enzo Biochem based in?

Enzo Biochem is headquartered in United States

When did Enzo Biochem go public?

Enzo Biochem's initial public offering (IPO) was on June 12, 1980

Is Enzo Biochem in the S&P 500?

No, Enzo Biochem is not included in the S&P 500 index

Is Enzo Biochem in the NASDAQ 100?

No, Enzo Biochem is not included in the NASDAQ 100 index

Is Enzo Biochem in the Dow Jones?

No, Enzo Biochem is not included in the Dow Jones index

When was Enzo Biochem's last earnings report?

Enzo Biochem's most recent earnings report was on Mar 17, 2025

When does Enzo Biochem report earnings?

The next expected earnings date for Enzo Biochem is Jun 13, 2025
On this page